Canna~Fangled Abstracts

Cannabidiol in the management of bruxism in behavioral variant of frontotemporal degeneration

By May 2, 2021May 3rd, 2021No Comments

doi: 10.1080/13554794.2021.1917620.

Online ahead of print.
Affiliations 

Abstract

Awake bruxism is an understudied feature of behavioral variant of frontotemporal dementia (bvFTD). We present the case of aman who presented with psychiatric, behavioral, cognitive changes, and teeth clenching that resulted in significant changes in his teeth alignment including an underbite. He received multiple treatments with partial response. He then started using a cannabidiol (CBD) capsule, and the grinding was almost completely relieved after this intervention. There is still no standardized pharmacology treatment for bruxism in patients with bv FTD. As a consequence, a case-by-case approach is suggested. CBD can be helpful as an adjunct therapeutic agent for awake bruxism.

Keywords: Bruxism, behavioral variant of frontotemporal dementia, cannabidiol


Leave a Reply

en English
X